Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HDSN vs CCRN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HDSN Captures Overall Composite Edge (53.2 HOLD vs 52.5 HOLD), While CCRN Leads 4–2 on Growth & Valuation Pillars
HDSN Overall Winner
6-Pillar Tally: HDSN 2 – 4 CCRN
Matrix Metrics: HDSN 6 – 4 CCRN
As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Cross Country Healthcare Inc (CCRN) on higher Unified Composite conviction (53.2/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while CCRN wins 4–2 across the 6-pillar growth and valuation breakdown. HDSN trades at $4.25 (25.9x Forward P/E, 2.0% operating margin) versus CCRN at $13.25 (47.3x Forward P/E, -0.8% operating margin).
- Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. CCRN 52.5/100 HOLD) and 1.32β · 68% Vol risk profile, whereas CCRN leads top-line expansion (-17.8% YoY revenue growth, 12.61x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: HDSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile CCRN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HDSN vs CCRN
HDSN
Head-to-Head Winner
Hudson Technologies Inc
$4.25
-3.52% 1D
Market Cap
$186.5M
TTM Revenue
$242M
Forward P/E
25.9x
Beta / 30D Vol
1.32β · 68% Vol
Unified Composite Score
53.2
HOLD
Tech 67.0
Fund 65.0
Flow 55.0
Mom 70.0
Weinstein Technical Phase
Markdown · Sell / avoid
CCRN
Cross Country Healthcare Inc
$13.25
+0.08% 1D
Market Cap
$427.7M
TTM Revenue
$1.00B
Forward P/E
47.3x
Beta / 30D Vol
0.50β · 2% Vol
Unified Composite Score
52.5
HOLD
Tech 40.0
Fund 50.0
Flow 69.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (HDSN 2 – 4 CCRN)
1. Valuation Multiples
HDSN
Forward P/E
25.9x
47.3x
Trailing P/E
16.5x
126.6x
PEG Ratio
0.29x
12.61x
EV / Revenue
0.6x
0.3x
2. Growth & Scale
CCRN
Revenue Growth (YoY)
-19.7%
-17.8%
Earnings Growth (YoY)
-82.0%
-78.5%
TTM Revenue (USD)
$242M
$1.00B
Market Cap
$186.5M
$427.7M
3. Profitability & Quality
HDSN
Gross Margin
21.0%
20.2%
Operating Margin
2.0%
-0.8%
Net Profit Margin
-0.5%
-9.8%
Return on Equity (ROE)
-0.5%
-27.0%
4. Balance Sheet & Cash Flow
CCRN
Cash Generation (TTM)
-$32M
$40M
Cash Flow Margin
-13.0%
4.0%
Net Cash / Leverage
$31M Net Cash
$104M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
CCRN
Options Structure Phase
BREAKDOWN
UNCLASSIFIED
Current IV / %ile
79.1% (15th %ile)
11.1% (4th %ile)
Put/Call OI Skew
N/A
0.76x (Call-Skewed)
OBV Trend / Tech Phase
ACCUMULATION · Markdown
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
CCRN
OpEx & R&D Intensity
19.0% of Rev ($46M)
21.0% of Rev ($210M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Specialty Chemicals Operator
Medical Care Facilities Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HDSN (6) vs CCRN (4)| Institutional Metric | HDSN | CCRN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $186.5M | $427.7M | CCRN | |
| Trailing P/E Ratio | 16.5x | 126.6x | HDSN | |
| Forward P/E Ratio | 25.9x | 47.3x | HDSN | |
| Revenue Growth (YoY) | -19.7% | -17.8% | CCRN | |
| Operating Margin (TTM) | 2.0% | -0.8% | HDSN | |
| Net Profit Margin | -0.5% | -9.8% | HDSN | |
| Return on Equity (ROE) | -0.5% | -27.0% | HDSN | |
| 52-Week Range Position | 6% ($4–$8) | 77% ($7–$15) | CCRN | |
| Beta / 30D Volatility | 1.32β · 68% Vol | 0.50β · 2% Vol | CCRN | |
| Unified Institutional Score | 53.2 / 100 (HOLD) | 52.5 / 100 (HOLD) | HDSN | |
| Trailing 12M Revenue (USD) | $242M | $1.00B | Scale | |
| Gross Profit Margin (TTM) | 21.0% | 20.2% | Quality | |
| PEG Ratio & EV / Revenue | 0.29x PEG · 0.6x EV/Rev | 12.61x PEG · 0.3x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$32M ($31M Net Cash) | $40M ($104M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
HDSN +7.92 pp
3M Horizon
CCRN +38.01 pp
6M Horizon
CCRN +63.09 pp
1Y Horizon
CCRN +32.83 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | HDSN Revenue | CCRN Revenue | HDSN Op. Margin | CCRN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $170M | $820M | -25.6% | -1.6% | CCRN |
| FY2019 | $160M | $820M | -9.7% | -1.9% | CCRN |
| FY2020 | $150M | $840M | 4.0% | -1.1% | HDSN |
| FY2021 | $190M | $1.68B | 21.9% | 8.3% | HDSN |
| FY2022 | $330M | $2.80B | 40.4% | 9.6% | HDSN |
| FY2023 | $290M | $2.02B | 27.0% | 5.6% | HDSN |
| FY2024 | $240M | $1.34B | 12.4% | -1.3% | HDSN |
| FY2025 | $250M | $1.05B | 7.5% | -8.0% | HDSN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HDSN
BREAKDOWN
Current IV
79.1%
IV Percentile
15th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact HDSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
CCRN
UNCLASSIFIED
Current IV
11.1%
IV Percentile
4th %ile
Put/Call OI Skew
0.76x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact CCRN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HDSN Moat Profile
Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
OpEx & R&D Reinvestment
19.0% of Rev ($46M)
90D Engineering Disclosures
0 Published
CCRN Moat Profile
Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
OpEx & R&D Reinvestment
21.0% of Rev ($210M)
90D Engineering Disclosures
0 Published
Investor FAQ HDSN vs CCRN Key Questions & Quantitative Answers
As of Nov 16, 2026, Hudson Technologies Inc (HDSN) captures the overall head-to-head institutional edge over Cross Country Healthcare Inc (CCRN) on higher Unified Composite conviction (53.2/100 HOLD vs. 52.5/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while CCRN wins 4–2 across the 6-pillar growth and valuation breakdown. HDSN trades at $4.25 (25.9x Forward P/E, 2.0% operating margin) versus CCRN at $13.25 (47.3x Forward P/E, -0.8% operating margin). Growth vs. Quality Trade-Off: HDSN earns the overall head-to-head edge with a stronger Unified Composite Score (53.2/100 HOLD vs. CCRN 52.5/100 HOLD) and 1.32β · 68% Vol risk profile, whereas CCRN leads top-line expansion (-17.8% YoY revenue growth, 12.61x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: HDSN is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile CCRN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 76.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CCRN leads the Growth & Scale pillar: HDSN posts -19.7% YoY revenue growth and -82.0% YoY earnings growth on $242M TTM revenue (21.0% gross margin, 2.0% operating margin), compared with CCRN at -17.8% YoY revenue growth and -78.5% YoY earnings growth on $1.00B TTM revenue (20.2% gross margin, -0.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HDSN cumulative revenue shifted +47.1% while CCRN shifted +28.0%. In operating R&D and SG&A reinvestment, HDSN deploys 19.0% of Rev ($46M) (0 90-day corporate R&D disclosures) versus 21.0% of Rev ($210M) (0 disclosures) for CCRN.
HDSN screens cheaper on headline valuation multiples. HDSN trades at 25.9x Forward P/E, 16.5x Trailing P/E, 0.29x PEG, and 0.6x EV/Revenue (-13.0% FCF margin), whereas CCRN trades at 47.3x Forward P/E, 126.6x Trailing P/E, 12.61x PEG, and 0.3x EV/Revenue (4.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HDSN (-0.5% ROE) versus CCRN (-27.0% ROE) capital efficiency.
In options market volatility and institutional positioning, HDSN carries 79.1% implied volatility (15th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.32β · 68% Vol realized risk). By comparison, CCRN carries 11.1% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.76x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
CCRN vs HDSN · Reverse Pair
HDSN vs RCMT
· Sector Peer
HDSN vs HNRG
· Sector Peer
HDSN vs STRR
· Sector Peer
CCRN vs KELYA
· Sector Peer
CCRN vs KFRC
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem